No insider purchase over the last 90 days. The latest was filed 11 Dec 2025.
Melexis, classified in the Technology sector, is a listed company based in Ypres, Belgium, founded in 1988. Its latest reported headcount is 1,934 employees (2025). Its insiders report their share dealings to FSMA. The last twelve months, up to 18 October 2026, brought 2 filings signed by 2 insiders.
Purchases and sales both appear in the filings: 1 purchase (1 insider, €629k) and 1 sale (1 insider, €629k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a purchase of €629k by Elex, published on 11 December 2025. On the buying side, the filings list 1 board member among the declarants.
Across the 77 companies tracked on its exchange, the median is 10 filings; at 2 filings, this issuer sits below that mark. Looking back to 2023, when coverage begins, insiders filed 3 purchases and 2 sales.
The last insider purchase was made public on 11 December 2025, 311 days ago.
In the same sector, recent insider purchases at Gitlab Inc. and Baozun Inc. also feature in our signals. This summary is built from FSMA disclosures alone and does not predict where the share price will go.
Headquarters: Ypres, Belgium · Founded: 1988 · 1,934 employees (2025)
Source: Wikidata (CC0).
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Melexis Buy (bullish), based on 13 analysts. Average price target: €75.92.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
6 of 6 declarations
Melexis is a company specializing in the design of semiconductors for automotive and other industrial applications. It is listed on the Brussels stock market (XBRU).
Purchases our model currently ranks for the recommendations list.
All recommendations